L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353 · cited 2×
“Chronic L-DOPA treatment, which induced dyskinesia and aberrant FosB expression, restored spine density in D2R-MSNs but not in D1RMSNs.”
BackgroundUneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953 · cited 1×
“An almost complete loss of dopaminergic fibers in the motor region of the striatum results in the profound akinesia that characterizes advanced Parkinson’s disease (PD) (1).”
BackgroundModulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718 · cited 1×
“Previous work has shown dual effects of D1R on MSN excitability through the modulation of sodium-, potassium-, and calcium-voltage-dependent currents, which are available at different membrane potentials observed in vivo (50,51).”
BackgroundKawaguchi, Y. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-11-04908.1993 · Cited by 814 · cited 1×
“The MSNs were identified by firing patterns (29).”
BackgroundDay, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745
Robinson, T. E., & Kolb, B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08491.1997 · Cited by 704
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
Hernández-López, S., Bargas, J., Surmeier, D. J., Reyes, A., & Galarraga, E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03334.1997 · Cited by 495 · cited 1×
“Previous work has shown dual effects of D1R on MSN excitability through the modulation of sodium-, potassium-, and calcium-voltage-dependent currents, which are available at different membrane potentials observed in vivo (50,51).”
BackgroundSantini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J.-A., Herve, D., Greengard, P., & Fisone, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0852-07.2007 · Cited by 437
Robinson, T. E., Gorny, G., Mitton, E., & Kolb, B. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<257::aid-syn1007>3.0.co;2-1 · Cited by 402
Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 387
Pavón, N., Martín, A. B., Mendialdua, A., & Moratalla, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.044 · Cited by 341 · cited 9×
“Induction of Dyskinesias in 6-OHDA-Lesioned Mice To quantify L-DOPA-induced dyskinesias in parkinsonian WT, D1R-tomato, or D2R-eGFP mice, we scored orofacial, limb, and locomotive dyskinesia 30 min after L-DOPA or saline injection as previously described (14,16,26).”
BackgroundMethodResultInfluentialSelf-citationElectrophysiology of dopamine-denervated striatal neurons
Brink, E. E., & Mackel, R. G. (1993) · Brain · doi:10.1093/brain/116.2.433 · Cited by 320 · cited 3×
“Because no D1R enhancing effect on excitability is seen in slices from sham mice treated with L-DOPA (32,52), it must be considered as an abnormal response to nigrostriatal denervation, which is further enhanced in dyskinesias.”
BackgroundResultThe pyramidal cell in cognition: a comparative study in human and monkey
Elston, G. N., Benavides-Piccione, R., & DeFelipe, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-j0002.2001 · Cited by 317 · cited 1×
“Immunostaining was performed in free-floating sections with standard avidin-biotin protocols (27) with the following rabbit antisera: TH (1:1000; Chemicon, Temecula, California); FosB (1:7,500; Santa Cruz Biotechnology, Santa Cruz, California); and Lucifer-Yellow (1:100,000) (28).”
MethodDendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., & Montine, T. J. (2005) · Neurology · doi:10.1212/01.wnl.0000150591.33787.a4 · Cited by 300 · cited 1×
“Although the available human studies included control subjects without any known brain pathology, all PD patients in these studies received L-DOPA chronically (4,5).”
BackgroundIngham, C. A., Hood, S. H., Taggart, P., & Arbuthnott, G. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04732.1998 · Cited by 291 · cited 1×
“density in totally denervated areas of WT mice (Figure 5B), as previously demonstrated (7).”
ResultEvidence of a breakdown of corticostriatal connections in Parkinson’s disease
Stephens, B., Mueller, A. J., Shering, A. F., Hood, S. H., Taggart, P., Arbuthnott, G. W., Bell, J. E., Kilford, L., Kingsbury, A. E., Daniel, S. E., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.007 · Cited by 284 · cited 1×
“Although the available human studies included control subjects without any known brain pathology, all PD patients in these studies received L-DOPA chronically (4,5).”
BackgroundFerrario, C. R., Gorny, G., Crombag, H. S., Li, Y., Kolb, B., & Robinson, T. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.046 · Cited by 283
Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C., & Cenci, M. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.032 · Cited by 277 · cited 3×
“Chronic L-DOPA treatment, which induced dyskinesia and aberrant FosB expression, restored spine density in D2R-MSNs but not in D1RMSNs.”
BackgroundMethodDarmopil, S., Martín, A. B., De Diego, I. R., Ares, S., & Moratalla, R. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.025 · Cited by 271 · cited 6×
“Induction of Dyskinesias in 6-OHDA-Lesioned Mice To quantify L-DOPA-induced dyskinesias in parkinsonian WT, D1R-tomato, or D2R-eGFP mice, we scored orofacial, limb, and locomotive dyskinesia 30 min after L-DOPA or saline injection as previously described (14,16,26).”
BackgroundMethodResultInfluentialSelf-citationA Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia
Gardoni, F., Picconi, B., Ghiglieri, V., Polli, F., Bagetta, V., Bernardi, G., Cattabeni, F., Di Luca, M., & Calabresi, P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5326-05.2006 · Cited by 269
Calabresi, P., Mercuri, N., Stanzione, P., Stefani, A., & Bernardi, G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90239-9 · Cited by 262 · cited 1×
“Because no D1R enhancing effect on excitability is seen in slices from sham mice treated with L-DOPA (32,52), it must be considered as an abnormal response to nigrostriatal denervation, which is further enhanced in dyskinesias.”
BackgroundGranado, N., Ortiz, O., Suarez, L. M., Martin, E. D., Cena, V., Solis, J. M., & Moratalla, R. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm026 · Cited by 249 · cited 1×
“Immunostaining was performed in free-floating sections with standard avidin-biotin protocols (27) with the following rabbit antisera: TH (1:1000; Chemicon, Temecula, California); FosB (1:7,500; Santa Cruz Biotechnology, Santa Cruz, California); and Lucifer-Yellow (1:100,000) (28).”
MethodSelf-citationAtrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246 · cited 1×
“006 dendrites in patients with advanced PD treated with L-DOPA (3).”
BackgroundDifferential Excitability and Modulation of Striatal Medium Spiny Neuron Dendrites
Day, M., Wokosin, D., Plotkin, J. L., Tian, X., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1840-08.2008 · Cited by 243 · cited 1×
“It has been suggested that spine pruning after dopamine denervation is induced by an increase in glutamatergic transmission (8,37,38).”
BackgroundNorrholm, S. D., Bibb, J. A., Nestler, E. J., Ouimet, C. C., Taylor, J. R., & Greengard, P. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00560-2 · Cited by 238
Doig, N. M., Moss, J., & Bolam, J. P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1623-10.2010 · Cited by 233 · cited 1×
“The question then is: “Why does spine recovery occur selectively in D2R-MSNs?” Although morphological studies evidence a similar glutamatergic innervation to D1R- and to D2R-MSNs (41), electrophysiological studies (38) showed that D2R-MSNs have stronger cortical inputs and are more directly affected by cortical activi…”
BackgroundHallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., & Dunah, A. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0792-06.2006 · Cited by 225
Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age
Ingham, C. A., Hood, S. H., & Arbuthnott, G. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)91686-7 · Cited by 219
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
Meshul, C. K., Emre, N., Nakamura, C. M., Allen, C., Donohue, M. K., & Buckman, J. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00189-4 · Cited by 209 · cited 2×
“It is possible that L-DOPA restores striatal glutamatergic release to normal levels (39,40), producing a recovery of spines in MSNs.”
BackgroundCepeda, C., André, V. M., Yamazaki, I., Wu, N., Kleiman‐Weiner, M., & Levine, M. S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06038.x · Cited by 198 · cited 2×
“The question then is: “Why does spine recovery occur selectively in D2R-MSNs?” Although morphological studies evidence a similar glutamatergic innervation to D1R- and to D2R-MSNs (41), electrophysiological studies (38) showed that D2R-MSNs have stronger cortical inputs and are more directly affected by cortical activi…”
BackgroundBoraud, T., Bezard, E., Bioulac, B., & Gross, C. E. (2001) · Brain · doi:10.1093/brain/124.3.546 · Cited by 193
Santini, E., Alcacer, C., Cacciatore, S., Heiman, M., Hervé, D., Greengard, P., Girault, J., Valjent, E., & Fisone, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05831.x · Cited by 187 · cited 1×
“Previous studies have shown that dyskinesias in parkinsonian mice are related to increased phosphorylation of extracellular signal-regulated kinase–1/2 and augmented expression of ΔFosB and prodynorphin in the striatum [(26,31) reviewed in (19)].”
BackgroundFeyder, M., Bonito-Oliva, A., & Fisone, G. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00071 · Cited by 171
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
Villalba, R. M., Lee, H., & Smith, Y. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.025 · Cited by 171 · cited 2×
“(10) in l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)–lesioned monkeys, but Villalba et al.”
BackgroundLevodopa-Induced Dyskinesia Is Strongly Associated with Resonant Cortical Oscillations
Halje, P., Tamté, M., Richter, U., Mohammed, M., Cenci, M. A., & Petersson, P. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3047-12.2012 · Cited by 162
Electrophysiology of dopamine in normal and denervated striatal neurons
Calabresi, P., Centonze, D., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00017-3 · Cited by 159
Corvol, J.-C., Muriel, M.-P., Valjent, E., Féger, J., Hanoun, N., Girault, J.-A., Hirsch, E. C., & Hervé, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0676-04.2004 · Cited by 158
Synaptically driven state transitions in distal dendrites of striatal spiny neurons
Plotkin, J. L., Day, M., & Surmeier, D. J. (2011) · Nature Neuroscience · doi:10.1038/nn.2848 · Cited by 151 · cited 7×
“Then, in MPTP-lesioned monkeys, Scholz et al. (9) confirmed www.sobp.org/journal spine depletion in D2R-MSN but showed an augmented spine density in D1R-MSNs.”
BackgroundInfluentialHirano, S., Asanuma, K., Ma, Y., Tang, C., Feigin, A., Dhawan, V., Carbon, M., & Eidelberg, D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0582-08.2008 · Cited by 141
PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
Porras, G., Berthet, A., Dehay, B., Li, Q., Ladepeche, L., Normand, E., Dovero, S., Martinez, A., Doudnikoff, E., Martin-Négrier, M.-L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59426 · Cited by 129
Dupre, K. B., Ostock, C. Y., Eskow Jaunarajs, K. L., Button, T., Savage, L. M., Wolf, W., & Bishop, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.02.012 · Cited by 122 · cited 1×
“It is possible that L-DOPA restores striatal glutamatergic release to normal levels (39,40), producing a recovery of spines in MSNs.”
BackgroundMurer, M. G., & Moratalla, R. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00051 · Cited by 118 · cited 2×
“(18,19), but enhanced D1R signaling in addiction induces an”
BackgroundSelf-citationDumitriu, D., LaPlant, Q., Grossman, Y. S., Dias, C., Janssen, W. G., Russo, S. J., Morrison, J. H., & Nestler, E. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5718-11.2012 · Cited by 107
Fasano, S., D'Antoni, A., Orban, P. C., Valjent, E., Putignano, E., Vara, H., Pizzorusso, T., Giustetto, M., Yoon, B., Soloway, P., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.014 · Cited by 106 · cited 1×
“(18,19), but enhanced D1R signaling in addiction induces an”
BackgroundAndré, V. M., Cepeda, C., Cummings, D. M., Jocoy, E. L., Fisher, Y. E., William Yang, X., & Levine, M. S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07047.x · Cited by 95 · cited 8×
“Then, in MPTP-lesioned monkeys, Scholz et al. (9) confirmed www.sobp.org/journal spine depletion in D2R-MSN but showed an augmented spine density in D1R-MSNs.”
BackgroundInfluentialDynamics of the Parkinsonian Striatal Microcircuit: Entrainment into a Dominant Network State
Jáidar, O., Carrillo‐Reid, L., Hernández, A., Drucker-Colín, R., Bargas, J., & Hernández‐Cruz, A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1380-10.2010 · Cited by 93
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat
Taylor, J. L., Bishop, C., & Walker, P. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.013 · Cited by 83
Guigoni, C., Doveró, S., Aubert, I., Li, Q., Bioulac, B. H., Bloch, B., Gurevich, E. V., Gross, C. E., & Bézard, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04196.x · Cited by 82
Homeostatic Plasticity of Striatal Neurons Intrinsic Excitability following Dopamine Depletion
Azdad, K., Chàvez, M., Bischop, P. D., Wetzelaer, P., Marescau, B., De Deyn, P. P., Gall, D., & Schiffmann, S. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006908 · Cited by 77 · cited 3×
“It has been proposed that the high basal excitability of MSN in nontreated dopamine-depleted animals represents a homeostatic mechanism that maintains neuronal firing despite the loss of excitatory synapses (34).”
BackgroundResultStriatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure
Scholz, B., Svensson, M., Alm, H., Sköld, K., Fälth, M., Kultima, K., Guigoni, C., Doudnikoff, É., Li, Q., Crossman, A. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001589 · Cited by 51
Delfino, M., Kalisch, R., Czisch, M., Larramendy, C., Ricatti, M. J., Taravini, I. R. E., Trenkwalder, C., Murer, M. G., Auer, D. P., & Gershanik, O. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301329 · Cited by 43 · cited 1×
“to D1 agonists (15), we tested the hypothesis that striatal MSNs”
BackgroundSelf-citationNisenbaum, E. S., Mermelstein, P. G., Wilson, C. J., & Surmeier, D. J. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199807)29:3<213::aid-syn3>3.0.co;2-9 · Cited by 43
D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism
Ballion, B., Frenois, F., Zold, C. L., Chetrit, J., Murer, M. G., & Gonon, F. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.019 · Cited by 39 · cited 1×
“Although specific studies in dyskinetic animals are lacking, indirect evidence suggests that L-DOPA treatment would inhibit the response of D2R-MSNs to cortical input (42,43).”
BackgroundSelf-citationAgatsuma, S., Dang, M. T., Li, Y., & Hiroi, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.023 · Cited by 15
Cited by
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways
Martín, R., Bajo-Grañeras, R., Moratalla, R., Perea, G., & Araque, A. (2015) · Science · doi:10.1126/science.aaa7945 · Cited by 312
Self-citationFieblinger, T., Graves, S. M., Sebel, L. E., Alcacer, C., Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Cenci, M. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6316 · Cited by 295
Blesa, J., Trigo-Damas, I., Dileone, M., del Rey, N. L.-G., Hernandez, L. F., & Obeso, J. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.002 · Cited by 256
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Moratalla, R., Khairnar, A., Simola, N., Granado, N., García-Montes, J. R., Porceddu, P. F., Tizabi, Y., Costa, G., & Morelli, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.011 · Cited by 225
“Interestingly, D1- and D2-containing projection neurons are segregated in the striatum, as well as in the nucleus accumbens (Callier et al., 2003; Beaulieu and Gainetdinov, 2011; Suárez et al., 2014).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Suárez, L. M., Solís, O., Caramés, J. M., Taravini, I. R., Solís, J. M., Murer, M. G., & Moratalla, R.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 75
- Issue
- 9
- Pages
- 711-722
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2034640913
- Cited by
- 179
- References
- 55
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.